Supply Issues Becton Dickinson UK Ltd Stock Oxford Administration Set Gravity Blood and Blood Derivatives FKA194 (ICN 3154)

Change:

• The supplier Becton Dickinson UK Ltd Stock Oxford has informed us of a supply issue with its Administration Set Gravity Blood and Blood Derivatives.
• There is one product affected:
  • FKA194 – Administration set gravity blood and blood derivatives Blood transfusion set double chamber wide bore with built in 3 way tap and 120cm wide bore extension set
• The supply issue is due to supplier manufacturing issues.
• Due to this ongoing supply issue this product is now being threshold managed as it is subject to Protect Demand Management.

Impact:

• FKA194 is available to order through NHS Supply Chain while our current stocks last. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• A potential indirect alternative product is available to order through our online catalogue:
  • FSB1884 Administration set gravity blood and blood derivatives, Double chamber blood set with 200um filter142cm tubing (4mm ID) 3-way connector 142cm extension tubing rotating luer connector.
• We are currently sourcing further alternatives and updates will be made to the product listing as soon as possible.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 2 January 2026.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative product and to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.